BioSpace News Archive

Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the expansion of its executive leadership team with Mark Przekop joining as Chief Operating Officer.

IN8bio, Inc. today announced the appointment of Corinne Epperly, MD, MPH, to its Board of Directors.

Secura Bio, Inc. today announces that it has added two members to the board of directors of Secura Bio Holdings, Inc.

Harmony Biosciences Holdings, Inc. today announced positive topline results from its Phase 2 signal detection study evaluating the safety and efficacy of pitolisant in adult patients with myotonic dystrophy type 1 (DM1).

Exact Sciences announced today that it awarded $1.3 million to 23 organizations through its Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) Program.

FORE Biotherapeutics today announced that the Company will be presenting at the 2023 RBC Capital Markets Private Company Conference.

Aura Biosciences Inc. today announced the first patient has been dosed in the global Phase 3 CoMpass trial evaluating the safety and efficacy of bel-sar for the first-line treatment of adult patients with early-stage choroidal melanoma.

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the completion of patient enrollment in the Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV).

Ryvu Therapeutics today announced promising translational data on RVU120 in combination with MEK inhibitors at the San Antonio Breast Cancer Symposium (SABCS) 2023.

LIB Therapeutics Inc. announced the appointment of Ingrid Choong, PhD as Chief Business Officer.